Post-doctoral position in metabolism and disease
ABG-128561 | Job | Junior |
2025-02-13 | Fixed-term 24 Month | > €35,000 and < €45,000 annual gross |

- Biology
- Health, human and veterinary medicine
Employer
We are a small but very active research group, which is part of the Duve Institute, a multi-disciplinary and international biomedical research institute of the UCLouvain in Brussels. We are experts in regulation of intermediate metabolism, in enzymology and pioneers in the discovery of “metabolite-repair enzymes” and their involvement in the new class of “Inborn Errors of Metabolite repair”.
Position and assignments
We focus on unraveling metabolic mechanisms underlying enzymatic defects, particularly those observed in Inborn Errors of Metabolism. Our lab discovered that neutropenia, which leads to severe infections in patients with Glycogen Storage Disease type Ib (GSD1b) and G6PC3 deficiency, is caused by the accumulation of a glucose metabolism inhibitor in neutrophils (Veiga-da-Cunha et al., PNAS, 2019).
This breakthrough led to the development of a new treatment that has since become the standard of care, significantly improving clinical outcomes for these patients (Wortmann et al., Blood, 2020; Boulanger et al., JIMD, 2022). However, we believe there is room for further optimization. A key focus of our current research is enhancing this treatment based on our recent identification of SGLT5 as a crucial renal transporter for managing neutropenia in these patients (Diederich et al., Cell Mol. Life Sci., 2023).
Beyond our work on neutropenia, our lab has a longstanding interest in glucose metabolism regulation, particularly glucose phosphorylation. In this context, we are investigating the pathophysiological mechanisms behind two neurodevelopmental diseases:
• PGM2L1 deficiency (Morava et al., AJHG, 2021)
• de novo mutations in hexokinase 1 (Wortmann et al., Neurol Genet., 2024)
To address these complex metabolic questions, we employ state-of-the-art metabolic analysis techniques, combining cell culture and mouse models with biochemical and enzymatic approaches.
Geographic mobility:
Telework
Starting date
Profile
We ask for a PhD degree in biomedical or biochemical sciences. Experience in cell biology, mastering cell culture techniques, metabolomics, enzymology and/or experience with working with mouse models are assets.
We are looking for highly motivated and dedicated researchers, quality-oriented with a strong interest in fundamental research questions related to biochemistry and metabolism.
A good command of English (spoken and written) is a plus.
Vous avez déjà un compte ?
Nouvel utilisateur ?
Get ABG’s monthly newsletters including news, job offers, grants & fellowships and a selection of relevant events…
Discover our members
PhDOOC
Institut Sup'biotech de Paris
Institut de Radioprotection et de Sureté Nucléaire - IRSN - Siège
Laboratoire National de Métrologie et d'Essais - LNE
CASDEN
CESI
ADEME
ANRT
ONERA - The French Aerospace Lab
Tecknowmetrix
TotalEnergies
Généthon
Ifremer
MabDesign
Nokia Bell Labs France
MabDesign
SUEZ
Aérocentre, Pôle d'excellence régional
Groupe AFNOR - Association française de normalisation